Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03807479
Title Study in Patients With Chronic Leukemia, Where Previous Therapy Failed, and Who Will be Treated With Ponatinib as Second Line Therapy (PONS)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors GWT-TUD GmbH

chronic myeloid leukemia



Age Groups: senior | adult
Covered Countries DEU

No variant requirements are available.